Understanding obesity’s impact across the disease spectrum
By ICON Biotech
Nearly 3 million people die every year due to obesity; the condition’s implications across inflammatory, metabolic and cardiovascular health are huge, and more people are affected by it than ever. As this free whitepaper explains, treatment, drug development and clinical trials for obesity need to adapt. ICON’s integrated approach to obesity studies and wide-ranging therapeutic expertise can help clinical developers of all sizes keep abreast of change. Fill in your details to find out more.